Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.


Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
30 08 2022
Historique:
pubmed: 2 8 2022
medline: 3 9 2022
entrez: 1 8 2022
Statut: ppublish

Résumé

Fecal communities transplanted into individuals can eliminate recurrent Clostridioides difficile infection (CDI) with high efficacy. However, this treatment is only used once CDI becomes resistant to antibiotics or has recurred multiple times. We sought to investigate whether a fecal community transplant (FCT) pretreatment could be used to prevent CDI altogether. We treated male C57BL/6 mice with either clindamycin, cefoperazone, or streptomycin and then inoculated them with the microbial community from untreated mice before challenge with C. difficile. We measured colonization and sequenced the V4 region of the 16S rRNA gene to understand the dynamics of the murine fecal community in response to the FCT and C. difficile challenge. Clindamycin-treated mice became colonized with C. difficile but cleared it naturally and did not benefit from the FCT. Cefoperazone-treated mice became colonized by C. difficile, but the FCT enabled clearance of C. difficile. In streptomycin-treated mice, the FCT was able to prevent C. difficile from colonizing. We then diluted the FCT and repeated the experiments. Cefoperazone-treated mice no longer cleared C. difficile. However, streptomycin-treated mice colonized with 1:10

Identifiants

pubmed: 35913161
doi: 10.1128/mbio.01364-22
pmc: PMC9426422
doi:

Substances chimiques

Anti-Bacterial Agents 0
RNA, Ribosomal, 16S 0
Clindamycin 3U02EL437C
Cefoperazone 7U75I1278D
Streptomycin Y45QSO73OB

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0136422

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI090871
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM099514
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007528
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK034933
Pays : United States

Références

Nature. 2018 Mar 29;555(7698):623-628
pubmed: 29555994
Int J Antimicrob Agents. 2016 Jul;48(1):1-10
pubmed: 27216385
Microbiome. 2013 Jan 09;1(1):3
pubmed: 24467987
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
pubmed: 17586664
Lancet. 1989 May 27;1(8648):1156-60
pubmed: 2566734
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Curr Protoc Microbiol. 2009 Feb;Chapter 9:Unit9A.1
pubmed: 19235151
mBio. 2022 Aug 30;13(4):e0118322
pubmed: 35856563
Sci Transl Med. 2018 Sep 26;10(460):
pubmed: 30257956
Appl Environ Microbiol. 2013 Sep;79(17):5112-20
pubmed: 23793624
mSphere. 2021 May 5;6(3):
pubmed: 33952668
Cancer Prev Res (Phila). 2018 Jul;11(7):393-402
pubmed: 29636352
Clin Infect Dis. 2021 Jun 15;72(12):2132-2140
pubmed: 32255488
Appl Environ Microbiol. 2009 Dec;75(23):7537-41
pubmed: 19801464
mSystems. 2017 Jul 25;2(4):
pubmed: 28761936
EMBO Rep. 2013 Apr;14(4):319-27
pubmed: 23478337
Clin Microbiol Infect. 2021 Dec;27(12):1777-1783
pubmed: 34245901
mSphere. 2019 Jan 30;4(1):
pubmed: 30700514
Dig Dis Sci. 2022 Jul;67(7):2899-2911
pubmed: 34259969
J Appl Microbiol. 2004;97(6):1166-77
pubmed: 15546407
Anaerobe. 2018 Oct;53:64-73
pubmed: 29654837
mSphere. 2020 Oct 21;5(5):
pubmed: 33087520
mSphere. 2018 Jun 27;3(3):
pubmed: 29950381
PLoS Comput Biol. 2015 May 07;11(5):e1004226
pubmed: 25950956
Anaerobe. 2021 Apr;68:102230
pubmed: 32615270
PLoS Comput Biol. 2013;9(12):e1003388
pubmed: 24348232
J Clin Gastroenterol. 2022 Jan 20;:
pubmed: 35050941
mSphere. 2020 Jul 29;5(4):
pubmed: 32727857
Lancet Gastroenterol Hepatol. 2021 Apr;6(4):282-291
pubmed: 33631102
mSystems. 2020 Feb 4;5(1):
pubmed: 32019832
Microbiol Mol Biol Rev. 2019 Jun 5;83(3):
pubmed: 31167904
J Infect Dis. 2016 Jul 15;214(2):173-81
pubmed: 26908752
Nat Med. 2020 Apr;26(4):608-617
pubmed: 32066975
N Engl J Med. 2019 Nov 21;381(21):2043-2050
pubmed: 31665575
Nature. 2015 Jan 8;517(7533):205-8
pubmed: 25337874
J Clin Gastroenterol. 2014 Sep;48(8):693-702
pubmed: 24440934
J Vis Exp. 2016 Dec 10;(118):
pubmed: 28060346
PLoS Pathog. 2012;8(10):e1002995
pubmed: 23133377
mSphere. 2021 Oct 27;6(5):e0062921
pubmed: 34585964
Science. 2017 Aug 11;357(6351):570-575
pubmed: 28798125
Infect Immun. 2012 Nov;80(11):3786-94
pubmed: 22890996

Auteurs

Nicholas A Lesniak (NA)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Sarah Tomkovich (S)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Andrew Henry (A)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Ana Taylor (A)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Joanna Colovas (J)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Lucas Bishop (L)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Kathryn McBride (K)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Patrick D Schloss (PD)

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, Michigan, USA.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH